AAAAAA

   
Results: 1-9 |
Results: 9
Impact of genotypic resistance testing on physician selection of antiretroviral therapy
Authors: Jones, S Klotman, ME
Citation: S. Jones et Me. Klotman, Impact of genotypic resistance testing on physician selection of antiretroviral therapy, J HUMAN VIR, 4(4), 2001, pp. 214-216
Development of a novel screen for protease inhibitors
Authors: Gillim, L Gusella, GL Vargas, J Marras, D Klotman, ME Cara, A
Citation: L. Gillim et al., Development of a novel screen for protease inhibitors, CL DIAG LAB, 8(2), 2001, pp. 437-440
Nephropathy and establishment of a renal reservoir of HIV type 1 during primary infection
Authors: Winston, JA Bruggeman, LA Ross, MD Jacobson, J Ross, L D'Agati, VD Klotman, PE Klotman, ME
Citation: Ja. Winston et al., Nephropathy and establishment of a renal reservoir of HIV type 1 during primary infection, N ENG J MED, 344(26), 2001, pp. 1979-1984
HIV envelope gp120 activates human arterial smooth muscle cells
Authors: Schecter, AD Berman, AB Yi, L Mosoian, A McManus, CM Berman, JW Klotman, ME Taubman, MB
Citation: Ad. Schecter et al., HIV envelope gp120 activates human arterial smooth muscle cells, P NAS US, 98(18), 2001, pp. 10142-10147
Renal epithelium is a previously unrecognized site of HIV-1 infection
Authors: Bruggeman, LA Ross, MD Tanji, N Cara, A Dikman, S Gordon, RE Burns, GC D'Agati, VD Winston, JA Klotman, ME Klotman, PE
Citation: La. Bruggeman et al., Renal epithelium is a previously unrecognized site of HIV-1 infection, J AM S NEPH, 11(11), 2000, pp. 2079-2087
CD8(+) cell lines isolated from HIV-1-infected children have potent soluble HIV-1 inhibitory activity that differs from beta-chemokines
Authors: Mosoian, A Teixeira, A Caron, E Piwoz, J Klotman, ME
Citation: A. Mosoian et al., CD8(+) cell lines isolated from HIV-1-infected children have potent soluble HIV-1 inhibitory activity that differs from beta-chemokines, VIRAL IMMUN, 13(4), 2000, pp. 481-495
Single-dose safety, pharmacology, and antiviral activity of the human immunodeficiency virus (HIV) type 1 entry inhibitor PRO 542 in HIV-infected adults
Authors: Jacobson, JM Lowy, I Fletcher, CV O'Neill, TJ Tran, DNH Ketas, TJ Trkola, A Klotman, ME Maddon, PJ Olson, WC Israel, RJ
Citation: Jm. Jacobson et al., Single-dose safety, pharmacology, and antiviral activity of the human immunodeficiency virus (HIV) type 1 entry inhibitor PRO 542 in HIV-infected adults, J INFEC DIS, 182(1), 2000, pp. 326-329
Transduction of renal cells in vitro and in vivo by adeno-associated virusgene-therapy vectors
Authors: Lipkowitz, MS Hanss, B Tulchin, N Wilson, PD Langer, JC Ross, MD Kurtzman, GJ Klotman, PE Klotman, ME
Citation: Ms. Lipkowitz et al., Transduction of renal cells in vitro and in vivo by adeno-associated virusgene-therapy vectors, J AM S NEPH, 10(9), 1999, pp. 1908-1915
HIV-associated nephropathy is a late, not early, manifestation of HIV-1 infection
Authors: Winston, JA Klotman, ME Klotman, PE
Citation: Ja. Winston et al., HIV-associated nephropathy is a late, not early, manifestation of HIV-1 infection, KIDNEY INT, 55(3), 1999, pp. 1036-1040
Risultati: 1-9 |